The move gives insurers some protection if a Republican bill to replace Obamacare becomes law. » Read More
By: Jake Novak
The GOP's Obamacare replacement bill still stinks. Here's what they need to do to get it right, says Jake Novak. » Read More
By: Laura Barrón-López
A measure by Rep. Tim Murphy could jeopardize pressure on coal companies to permanently fund retirees' health care, Huff Post reports. » Read More
By: Leigh Ann Caldwell and Alex Moe
President Donald Trump looks likely to pass his 100th day in office without successfully repealing Obamacare, NBCNews reports. » Read More
The Republican answer to health care aims to provide Americans with more choice, Health and Human Services Secretary Tom Price tells CNBC.
Republican leaders have repeatedly tried to change the bill since an aborted vote last month.
In the process of raising $1 billion for early cancer detection, start-up Grail has added venture capital veteran Brook Byers to board.
It's uncertain whether moderate Republicans will provide enough votes for passage in the House.
Anthem said it plans to file preliminary 2018 rates with the assumption that the cost-sharing reductions will be funded.
The FDA has denounced claims about herbal products and other cancer-fighting treatments as "false" and "dangerous," NBC News reports.
This health care amendment doesn’t do much to resolve concerns over the older proposals, Vox reports.
EpiPen's seller Mylan drew criticism last summer for having hiked its price by more than 500 percent over the past decade.
Soaring insulin prices and inflexible insurance policies have forced many parents to take desperate measures to keep their kids alive.
Doing this one thing can lead to improvements in cognitive abilities, regardless of your current brain health, David Oliver writes in US News & World Report.
Ending $10 billion in payments for cost-sharing assistance would lead to the U.S. to pay out more $12 billion in other subsidies.
Eli Lilly reported a bigger-than-expected profit as the drugmaker benefited from higher demand for its newer products including diabetes treatment Trulicity.
Novartis's first-quarter core net income fell 4 percent, it said on Tuesday.
The fact that Anthem wants to cut ties with Express Scripts is "perplexing," Express Scripts CEO Tim Wentworth told CNBC on Monday.
Any vote on healthcare legislation would be determined by Republican leaders when they have enough votes, White House spokesman Sean Spicer said.
Sanofi on Monday sued Mylan, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment
Get the best of CNBC in your inbox